Navigation Links
FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS
Date:11/30/2009

(sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking Statement

This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the expectations of the development and potential approval of Huxley's 3,4-Diaminopyridine product for the treatment of LEMS. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: the content and timing of decisions by the U.S. Food and Drug Administration, the European Commission and other regulatory authorities, particularly the pending decision by the European Commission on the Marketing Authorization Application for such product, our success in the commercialization of such product, if approved; results and timing of current and planned preclinical studies and clinical trials related to such product; our ability to successfully manufacture the product; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2008 Annual Report on Form 10-K, and the factors contained in BioMarin's reports on Form 10-Q. Stockholders are urged not to place undue reliance on forward-lo
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Mirus Bio Awarded Grants & Contracts of Over $5 Million
2. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
3. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
4. NIH grants $750,000 to develop device to determine temperature of neonates brain
5. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
6. Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
7. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
8. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
9. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
10. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
11. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... OXFORD, England and CHICAGO ... Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a ... clinical and non-clinical data relating to the Company,s novel ... allergies will be presented at the 2015 European Academy ... in Barcelona, Spain on 6-10 ...
(Date:6/3/2015)... June 03, 2015 Photo-Eyewear™ ( ... name to PogoTec™, Inc. ( http://www.PogoTec.com ) to ... wearable device products and technologies it is developing and ... three business divisions, PogoTec™ will provide focused resources to ... follows: , , On-Track™ – There ...
(Date:6/3/2015)... Global Stem Cells Group ... plans to conduct Romania’s first ever stem cells harvesting ... with Miami-based Stem Cell Training, Inc., Cosmetic Surgeon ... Bone Marrow Stem Cell Training Course for medical professionals ... specialist practicing in Bucharest and Tel Aviv, Israel, and ...
(Date:6/2/2015)... , June 2, 2015 TapImmune, Inc. ... its institutional investors have reached an agreement whereby the ... short term warrants to provide the Company up to ... an effective S-1 registration statement. Under the restructured terms ... also call additional warrants which could result in a ...
Breaking Biology Technology:Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 3Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 3Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 2Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 3TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 2TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 3
... , ROCHESTER, N.Y., Sept. 21 According to Dr. ... Utah, "for the first time we have analyzed prostate cancer and normal ... XMRV virus] ... It was also more likely to be present in ... the least aggressive tumors and over 45 percent of the most aggressive ...
... , , , SAN CARLOS, ... it will be hosting a conference call to discuss today,s announcement of a ... a.m. Eastern Time (ET)/5:30 a.m. Pacific Time (PT). , , ... link that is posted on the home page of Nektar,s website: ...
... ... inventory Ultra-low Freezer and Liquid Nitrogen Tank samples and efficiently manage data of any ... ... announced the release of FreezerPro 2010, Frozen sample inventory and information management system (FSIIMS). ...
Cached Biology Technology:As Predicted: Chronic Virus Found Living in Tumors of the Prostate 2Nektar Therapeutics to Host Conference Call to Discuss Today's Announcement of a New Partnership for NKTR-118 and NKTR-119 2RURO Inc. Today Announced the Release of FreezerPro 2010, Frozen Sample Inventory and Information Management System 2
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... The National Human Genome Research Institute (NHGRI) of the ... three-year grant to establish a Wisconsin Center of Excellence ... effort between the University of Wisconsin in Madison, The ... be coordinated by the Medical College of Wisconsin. It ...
... rice to feed the world," says Dr. Robert Zeigler, director general ... and keep rice prices around US$300 a ton which allows ... for poor rice consumers we need to produce an additional ... for the next twenty years." Many countries do not have the ...
... CINCINNATIUsing an RNA-powered nanomotor, University of Cincinnati (UC) biomedical ... to transmit nanoscale material through a membrane. In ... Guo, PhD, members of the UC team inserted the ... into a lipid membrane. The resulting channel enabled them ...
Cached Biology News:Wisconsin Center of Excellence in Genomics Science established 2Wisconsin Center of Excellence in Genomics Science established 3'Land grabs' for rice production due to supply threats 2UC nanotech researchers develop artificial pore 2
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
... Mch3 Lyophilized solid. Highly active ... kinetics, cleavage of target substrates, and inhibitor screening. ... One unit is defined as the amount of enzyme ... 235400 per hour at 37 C at saturated substrate ...
HLA-DRbeta (DA2)...
Biology Products: